Latest results from the PUP-GCP clinical trial: a low inhibitor rate in previously untreated patients with severe hemophilia A treated with octanate

被引：0
|
作者：
Klukowska, A. [1 ]
Jansen, M. [2 ]
Komrska, V. [3 ]
Laguna, P. [1 ]
Vdovin, V. [4 ]
Knaub, S. [5 ]
机构：
[1] Med Univ Warsaw, Dept Paediat Haematol & Oncol, Warsaw, Poland
[2] Octapharma Prod Gesell mbH, Vienna, Austria
[3] Univ Hosp Motol, Dept Pediat Haematol & Oncol, Prague, Czech Republic
[4] Izmaylovo Childrens Hosp, Haematol Ctr, Moscow, Russia
[5] OCTAPHARMA AG, Clin R&D Dept, Lachen, Switzerland
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [11] Low inhibitor incidence in previously untreated hemophilia A patients (PUPs) treated with Octanate®
    Klukowska, A.
    Laguna, P.
    Komrska, V.
    Jansen, M.
    HAEMOPHILIA, 2010, 16 : 37 - 37
  • [12] Results from The Pup-GPC Clinical Trial: Low Inhibitor Rate in Previously Untreated Patients With Severe Haemophilia A Treated With A Plasma Derived FVIII Concentrate
    Klukowska, A.
    Knaub, S.
    Komrska, V.
    Laguna, P.
    Jansen, M.
    Lowndes, S.
    Vdovin, V.
    HAEMOPHILIA, 2015, 21 : 36 - 36
  • [13] Low inhibitor incidence in previously untreated haemophilia A patients treated with octanate
    Klukowska, A.
    Laguna, P.
    Jansen, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 373 - 373
  • [14] Absence of inhibitor development in previously treated patients and a low inhibitor incidence in previously untreated haemophilia A patients treated with Octanate®
    Jansen, M.
    Klukowska, A.
    Laguna, P.
    HAEMOPHILIA, 2008, 14 : 45 - 45
  • [15] Inhibitor development in relation to treatment duration in severe hemophilia A in previously untreated patients: results from the sippet trial
    Peyvandi, F.
    Mannucci, P. M.
    Garagiola, I
    Anzoletti, M. B.
    El-Beshlawy, A.
    El-Alfy, M.
    Madatha, V. R.
    Eshghi, P.
    Varadarajan, R.
    Hanagavadi, S.
    Karimi, M.
    Manglani, M., V
    Ross, C.
    Young, G.
    Seth, T.
    Apte, S.
    Nayak, D.
    Santagostino, E.
    Mancuso, E.
    Gonzalez, A. C. S.
    Owaidah, Tarek M.
    Rosendaal, F. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 321 - 322
  • [16] Exploration of biomarkers for early recognition of FVIII inhibitor development in previously untreated severe hemophilia A patients: Hemophilia Inhibitor PUP Study and beyond
    Hofbauer, C. J.
    Male, C.
    Brown, D.
    Santagostino, E.
    Oldenburg, J.
    Scheiflinger, F.
    Reipert, B. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 133 - 133
  • [17] Inhibitor development in previously untreated patients (PUP's) with hemophilia A treated with Kogenate(R): (GIPSI - German Italian PUP study on inhibitor development)
    Ettingshausen, CE
    Gringeri, A
    Budde, U
    Mannucci, PM
    Kreuz, W
    Lusher, J
    BLOOD, 1997, 90 (10) : 687 - 687
  • [18] Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate®: Final report from a prospective study
    Klukowska, A.
    Komrska, V.
    Vdovin, V.
    Pavlova, A.
    Jansen, M.
    Lowndes, S.
    Belyanskaya, L.
    Walter, O.
    Laguna, P.
    HAEMOPHILIA, 2018, 24 (02) : 221 - 228
  • [19] Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia A- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)
    Gangadharan, Bagirath
    Reipert, Birgit
    Scheiflinger, Fritz
    Bowen, Joel
    Donnachie, Elizabeth
    van Draat, Karin Fijn
    Gruppo, Ralph A.
    Klintman, Jenny
    Male, Christoph
    McGuinn, Catherine E.
    Meeks, Shannon L.
    Recht, Michael
    Ragni, Margaret V.
    Yaish, Hassan M.
    Shapiro, Amy D.
    Yee, Donald L.
    Radulescu, Vlad Calin
    Santagostino, Elena
    Brown, Deborah
    BLOOD, 2017, 130
  • [20] Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study
    Miri, Syna
    Rosendaal, Frits R.
    Kavakli, Kaan
    Eshghi, Peyman
    Moghaddam, Soha Mohammadi
    Scardo, Sara
    Habibpanah, Behnaz
    Elalfy, Mohsen
    Halimeh, Susan
    Nicolo, Gabriella
    Gokcebay, Dilek
    Ozbek, Namik
    Celkan, Tiraje
    Mohammadi, Ahmad
    Karimi, Mehran
    Shahsavani, Amin
    Yilmaz, Baris
    Albayrak, Canan
    Gunes, Burcak
    Kaya, Zuehre
    Ay, Yilmaz
    Akbayram, Sinan
    Sarper, Nazan
    Mannucci, Pier Mannuccio
    Peyvandi, Flora
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (08)
12345